神经肿瘤学与影像基因组学:是时候整合了吗?
本文综述探讨影像基因组学在颅内胶质瘤临床管理中的潜在应用场景,包括辅助患者咨询、在无法完成完整分子分型时优化管理、重新分类肿瘤及克服组织学评估的局限,并讨论根据临床情境选择相关影像基因组学特征的考量。
要点
- 影像基因组学旨在基于影像特征预测遗传标志物,但向临床转化有限。
- 综述提出影像基因组学可能辅助患者咨询、优化无法完整分子分型时的管理及肿瘤再分类。
- 选择相关影像基因组学特征需基于临床情境进行考量。
核心结论
- 影像基因组学技术虽快速发展且日益复杂,但向临床领域的转化有限,本综述旨在讨论其可能辅助患者管理的临床场景。
研究设计与样本
- 综述,讨论影像基因组学在神经肿瘤学中的临床应用场景及特征选择考量,未报告系统检索范围与纳入文献。
临床应用与阅片要点
- 作者认为影像基因组学可能有助于患者咨询、在无法完成完整分子分型时确定最佳患者管理、重新分类肿瘤以及克服组织学评估的部分局限。
局限性
- 尽管所研究的技术取得进展,但向临床领域的转化有限。
- 前沿研究与临床实践整合之间的脱节日益加剧。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiogenomics aims to predict genetic markers based on imaging features. The critical importance of molecular markers in the diagnosis and management of intracranial gliomas has led to a rapid growth in radiogenomics research, with progressively increasing complexity. Despite the advances in the techniques being examined, there has been little translation into the clinical domain. This has resulted in a growing disconnect between cutting-edge research and assimilation into clinical practice, though the fundamental goal is for these techniques to improve patient care. The goal of this review, therefore, is to discuss possible clinical scenarios in which the addition of radiogenomics may aid patient management. This includes facilitating patient counseling, determining optimal patient management when complete molecular characterization is not possible, reclassifying tumors, and overcoming some of the limitations of histologic assessment. The review also discusses considerations for selecting relevant radiogenomic features based on the clinical setting.
引用
- Lasocki A, Rosenthal MA, Roberts-Thomson SJ, et al. Neuro-Oncology and Radiogenomics: Time to Integrate? AJNR Am J Neuroradiol. 2020. PMID: 32912874. doi:10.3174/ajnr.A6769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。